United States: Wright Medical Technology Files Brief In Support Of Post-Trial Motions In Hip Implant Case

Last Updated: February 8 2016
Article by Evan M. Tager

A couple of months ago, we reported on a $10 million punitive verdict in the first hip implant case to go to trial against Wright Medical Technology. Last week, Wright Medical filed its opening brief in support of its post-trial motions.  From the looks of the brief, Wright Medical has a number of promising arguments.

To begin with, Wright would appear to have a compelling argument that it is entitled to either judgment or a new trial as a result of the jury's answers to questions on the verdict form and the trial court's response. The first question on the form asked the jury whether the plaintiff had proven that the hip replacement device was defectively designed and instructed the jury that, if it answered "no," it should stop, and sign and date the form—because it evidently was undisputed that there could be no liability under any theory if the device was not defective.  The jury did answer "no," but it continued to answer other questions on the form.

Most significantly, the jury (i) found that Wright Medical had made negligent misrepresentations about the device and that those misrepresentations caused harm to the plaintiff; (ii) found that the amount of that harm was $662,500; (iii) found that the plaintiff had established by clear and convincing evidence that Wright Medical's misrepresentations were willful and malicious, intentionally fraudulent, or knowingly and recklessly indifferent towards the rights of others, including the plaintiff; (iv) imposed punitive damages of $2.5 million; and (v) found that Wright Medical was 78.70% responsible for the plaintiff's harm and that the plaintiff was 21.24% responsible (leaving 0.06% unaccounted for).

Citing cases from other circuits, Wright Medical maintains that the verdict was complete after the jury answered the first question and that the remaining answers should have been disregarded. The district court, however, sent the jury back to reconsider and, to make matters worse, dismissed a juror who had complained about the tenor of the deliberations and the refusal of other jurors to listen to his arguments.  With this juror gone from the scene, the remaining jurors completely overhauled their responses to the questions on the verdict form.

This time around, the jury (i) found that the hip replacement device was defectively designed, that it was unreasonably dangerous, that the defect was present at the time that Wright Medical sold the device that was implanted in the plaintiff, that the plaintiff was harmed as a result, and that the amount of harm was $550,000; (ii) found that Wright Medical had made negligent misrepresentations, that those misrepresentations harmed the plaintiff, and that the amount of additional harm caused by the misrepresentations was $450,000; (iii) again found that the plaintiff had established by clear and convincing evidence that Wright Medical's misrepresentations were willful and malicious, intentionally fraudulent, or knowingly and recklessly indifferent towards the rights of others, including the plaintiff; (iv) increased the amount of punitive damages to $10 million; and (v) found that plaintiff bore no responsibility for her harm.

The dramatic changes in the jury's responses to the verdict form questions suggest that both the decision to resubmit the case to the jury and the decision to remove the juror were highly prejudicial to Wright Medical. Whether or not it is possible to rationalize each decision in isolation, when they are taken together, the appearance of unfairness seems so stark as to warrant a new trial.

Wright Medical also argues that the evidence was insufficient to support the jury's findings that it was negligent and that it engaged in negligent misrepresentations. Because I have no familiarity with the record, I won't comment on those arguments.

Wright Medical next contends both that negligent misrepresentation is not a valid predicate for punitive damages under the law of Utah and that, in any event, the plaintiff failed to adduce clear and convincing evidence that Wright Medical engaged in willful, malicious, or fraudulent conduct or that its conduct manifested a knowing and reckless indifference toward the rights of others. Again, I will have to forgo comment on these arguments because I lack familiarity with the record.  But it is worth noting that, given Utah's high standard for imposition of punitive damages, this may be a case in which the punitive award should be stricken even if the findings  of liability for the underlying torts are allowed to stand.  As we noted in a post a few months ago, the Kentucky Supreme Court recently drew such a line in a case involving an allegedly defective seat belt.

Finally, Wright Medical argues that the compensatory damages are excessive under Utah law and that the punitive damages are excessive under both Utah law and the due process clause.

The argument with respect to compensatory damages is essentially that the bulk of the $1 million award—all but $37,690.46 in stipulated medical expenses—is for pain and suffering and mental anguish, yet the evidence of such severe emotional harm is non-existent. According to Wright Medical's brief, the plaintiff had no problem with the implant until the day before it failed, and that once it did, it was quickly replaced, she had a speedy recovery, and she now has resumed all of her regular activities, including 50-mile bike rides, skiing in the Alps, and hiking.  Assuming that there is no countervailing evidence of severe pain and suffering, the argument for a substantial remittitur of the compensatory damages would appear to be compelling.

The argument that the punitive damages are excessive under Utah law rests on a 25-year-old Utah Supreme Court case that established a presumption that punitive/compensatory ratios in excess of 3:1 are excessive. Although the Utah courts have deviated from this presumption on occasion—including in State Farm Mutual Automobile Insurance Co. v. Campbell—this case does not appear to involve highly reprehensible conduct or other grounds that might warrant an exception.

As for the due process argument, although the Supreme Court has not established any hard-and-fast rules that lower courts must apply, it did indicate in State Farm that when the compensatory damages are substantial—and particularly when they contain a non-economic element that may duplicate the effect of punitive damages—a 1:1 ratio of punitive to compensatory damages may mark the constitutional line.  As I indicated in my prior post about this case, moreover, that is all the more true in a mass tort context when many other plaintiffs are seeking punitive damages for the same alleged conduct.  In fact, even a 1:1 ratio may be too high in such circumstances, depending on how many other plaintiffs there are and how high the compensatory damages are expected to be.

It should be interesting to see how the district court resolves the many significant issues raised by Wright Medical in this case. I assume that a decision is still several months away, but I will report on it once the court issues it.

Tags: Multiple punishment, ratio, Verdict Forms

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2016. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions